Asimadoline
Top View
- A Randomised Controlled Trial of Absorbatox™ C35 in Irritable Bowel
- Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects Of
- Stembook 2018.Pdf
- The Narcotic Bowel Syndrome
- Use of Asimadoline for the Treatment of Digestive Disorders
- Thesis Introduction
- Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: a Review Article Longtu Chen,1 Sheikh J
- Future of Minimizing Opioid Adverse Effects While Maintaining Or Improving Opioid-Related Analgesia
- Kappa Opioid Receptor Agonists: New Targets in the Treatment of Pain
- License Agreement of a Drug Candidate for Irritable Bowel Syndrome with Tioga
- Opioids for Chronic Noncancer Paina Systematic
- Opioid Receptor
- New Pharmaceutical Approaches to the Treatment of IBS: Future Development & Research
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- Gastrointestinal Targets of Appetite Regulation
- Asimadoline | Medchemexpress
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Sex Differences in Kappa Opioid Pharmacology